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FLOWE, K. M., K. M. LALLY AND M. W. MULHOLLAND. Galanin inhibits rat pancreatic amylase release via cholinergic 
suppression. PEPTIDES 13(3) 487-492, 1992.--The effects of galanin on pancreatic exocrine function were examined using rat 
pancreatic tissues. In anesthetized rats, galanin (40 t~g/kg/h) decreased amylase secretion stimulated by 2-deoxy glucose (5.8 + 
0.1 vs. 3.1 _+ 0.1 times basal) and cholecystokinin octapeptide (21.5 + 0.6 vs. 16.8 +_ 0.5), while not inhibiting bethanechol- 
stimulated secretion. In dispersed acini, there was no effect of galanin alone (10 -s to 10 -~3 M) on amylase release, nor did galanin 
(10 -6 or 10 -s M) coincubafion affect amylase release stimulated by bethanechoi (10 -3 to 10 -7 M) or CCK-8 (10 -s to 10 -~3 M). 
Using pancreatic lobules, eoincubation with galanin (10 -6 M) suppressed 75 mM KCl-stimulated amylase secretion and ACh 
release (10.1 + 0.6% vs. 7.3 + 0.4%). Veratridine-stimulated (10 -4 M) amylase secretion and ACh release (12.4 + 1.7% vs. 8.5 + 
0.7%) were similarly diminished. 
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GALANIN is a 29 amino acid peptide that was initially isolated 
from the porcine intestine (7). Galanin shares only minor se- 
quence homology with other known peptides and is expressed 
in both central and peripheral nervous systems (7,15,27). Gal- 
anin-immunoreactive nerve fibers are distributed widely 
throughout the digestive tract of a number of mammalian species 
(16). The peptide has been localized immunocytochemically to 
nerve fibers within both the endocrine and the exocrine portions 
of  the pancreas (9). 
To date, investigation of the pancreatic effects of galanin have 
focused mainly on the endocrine portion of the gland, although 
prior studies have suggested that galanin may inhibit exocrine 
function in rats and dogs (1,13,31). In rats and dogs, galanin 
inhibits the release of insulin and somatostatin and stimulates 
release of  glucagon (10,17). Galanin is released from intrapan- 
creatic nerves by mixed pancreatic nerve stimulation in con- 
centrations that axe sufficient to inhibit insulin secretion (11). 
Because of  these effects, and because the peptide is localized to 
nerves innervating acinar tissues, we investigated the effects of 
galanin on exocrine pancreatic function. 
The current study sought to employ in vivo and in vitro 
techniques to investigate potential inhibitory effects of galanin 
in the rat pancreas. The general goals of the investigation were 
to: 1) determine if galanin is an inhibitor in vivo of stimulated 
pancreatic exocrine function in rats 2) determine if inhibitory 
actions are exerted directly on the acinar cell; and 3) examine 
the ability ofgalanin to affect exocrine function by modulation 
of intrapanereatic neurotransmission. In order to achieve these 
goals, experiments were performed to: 1) determine if galanin 
inhibits stimulated amylase secretion in anesthetized rats; 2) de- 
termine if galanin affects amylase release from purified acini; 
and 3) determine ifgalanin decreases amylase secretion and ace- 
tylcholine release from pancreatic lobules, containing islet tissues 
and intrapancreatic neurons, in addition to acini. 
METHOD 
Supplies 
Rat galanin and cholecystokinin octapeptide (CCK-8) were 
obtained from Peninsula Laboratories, Belmont, CA. Peptides 
were reconstituted in 1% (w/v) bovine serum albumin to a con- 
centration of l0 -4 M. Aliquoted peptides were stored at - 4 0 ° C  
until use. Collagenase, 2-deoxy glucose (2-DG), bethanechol, 
atropine, veratridine, tetrodotoxin, bovine serum albumin (BSA), 
soybean trypsin inhibitor, and aprotinin were purchased from 
Sigma Chemical Company, St. Louis, MO. [3H]Methyl choline 
chloride was purchased from New England Nuclear, Boston, 
MA. [~4C]Acetylcholine was purchased from Amersham, Ar- 
lington Heights, IL. 
In Vivo Studies 
Male Sprague-Dawley rats from Charles River (Wilmington, 
MA), weighing 200-300 g, were used for all experiments. Ani- 
mals were cared for under specific pathogen-free guidelines prior 
to use, and housed at constant temperature with alternating light- 
dark cycles of 12 h. Rats received water ad lib and were fed 
Purina Rodent Laboratory Chow. After an overnight fast, during 
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which they were allowed water ad lib, rats were weighed and 
given an intraperitoneal injection of urethane, 1.25 mg/g body 
weight. Through a short midline laparotomy incision, the en- 
trance of the bile pancreatic duct into the duodenum was can- 
nulated with polyethylene tubing (PE-50, Becton-Dickinson, 
Parsippany, N J) for total diversion of endogenous bile pancreatic 
secretion. A duodenostomy tube was placed to allow reinfusion 
of previously harvested bile pancreatic juice. This juice was col- 
lected from other male Sprague-Dawley rats and stored at -20°C 
until reinfused. Intravenous access was secured via the femoral 
veins and normal saline was infused at a rate of 1.6 cc/h 
throughout the experiment. A tracheostomy was placed to insure 
a patent airway. 
After bile pancreatic flow was demonstrated, serial collection 
at 10-min intervals was maintained for 120 min. The volume 
of secretion for each interval was measured gravimetrically. 
Amylase activity was measured by the method of Bernfeld (6). 
All assays were performed in duplicate. 
Inhibitory effects were examined by infusing galanin (40 #g/ 
kg/h) continuously starting before 2-DG (100 mg/kg subcuta- 
neously), bethanechol (3 mg/kg/h intravenously), or CCK-8 (0.25 
ttg/kg/h intravenously). 
In Vitro Studies 
Dispersed acini. After an overnight fast, rats were weighed 
and sacrificed. The pancreas was harvested; adherent fat and 
lymphatic tissue was removed. The gland was cut into 12 to 15 
pieces and placed in chilled Krebs ringer HEPES buffer, pH 7.4. 
The buffer contained (each in mM) NaCI 103, KCI 4.8, KH2PO4 
1.2, glutamine 2, glucose 5, HEPES 25, CaCI2 1.3, and MgSO4, 
0.6. Also included were minimal essential media amino acids, 
1% (v/v) (GIBCO BRL, Gaithersburg, MD), nonessential amino 
acids, 0.5% (v/v) (GIBCO), and BSA, 0.2% (w/v). The pancreatic 
tissues were dispersed with collagenase as previously described 
(4,19,29). Briefly, under 100% oxygen, three 15-min collagenase 
(0.1 mg/ml buffer) digestions were performed at 37°C (with fresh 
buffer instilled between each digestion), and acini were then dis- 
persed by trituration with pipettes of decreasing tip diameter. 
Acini were diluted with buffer and aliquoted into tubes con- 
taining galanin alone, or into tubes containing stimulant plus 
either galanin or equal volume of 1% (w/v) BSA (control). The 
concentration range used for galanin alone was 10 -s to 10 -13 
M. Stimulant concentration ranges used were 10 -7 to 10 -3 M 
for bethanechol, and 10 -13 to 10 -8 M for cholecystokinin. Gal- 
anin concentration in the presence of  stimulant was either 10 -8 
M or 10 -6 M. After incubation at 37°C for 30 rain, the tubes 
were chilled and centrifuged. Amylase activity was determined 
in duplicate for the media and for the acini. Acini were lysed 
with a 0.1% Triton X-100 buffer, pH 8.0, containing 0.01 M 
NaH2PO4 and 0.1% BSA (w/v). Amylase release was expressed 
as percentage of total cellular content. Mean percent of total 
amylase release from duplicate incubations for each rat was used 
for statistical analysis. 
Isolated lobules. Amylase release. A technique modified from 
Scheele and Palade (24) was used for isolated lobule studies. 
After an overnight fast, rats were weighed and sacrificed. The 
pancreas was harvested and pinned to a wax plate. Using 2.0 
power optical magnification, individual lobules from throughout 
the pancreas were identified and excised, taking special care not 
to damage the pancreatic tissue with instruments. Lobules were 
kept in an oxygenated HEPES-biearbonate buffer, pH 7.4, during 
harvest. Buffer contained (each in mM) NaCI 103, KC1 4.7, 
CaCI2 2.6, MgCI2 1.1, NaH2PO4 1.2, glucose 11, HEPES 25, 
NaHCO3 25, and L-glutamine 2, as well as minimal essential 
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FIG. 1. Effects of galanin on 2-deoxy glucose (2-DG)-stimulated exocrine 
pancreatic function. Galanin (40 ~/kg/h) was infused from 20-120 rain, 
and 2-DG (100 mg/kg) was injected subcutaneoudy at 40 min~ All values 
for galanin-treated animals were sit, nifaumtly different from controls from 
50-120 rain for amylase release. Integrated amylase secretion was sig- 
nificantly decreased for rats receiving galanin infusion and 2-DG injection. 
For both groups, n = 6. 
amino acids, 2% (v/v), BSA, 1% (w/v), soybean trypsin inhibitor, 
0.1% (w/v), and aprotinin 680 KIU/ml. Four lobules were added 
to each incubation flask. The flasks contained buffer plus atropine 
10 -5 M, tetrodotoxin 10 -5 M, galanin 10 -s or 10 -6 M, or above 
medium alone. After a 30-min incubation at 37°C under a 95% 
02/5% CO2 atmosphere, the lobules were washed. A second in- 
cubation was then performed including agonists (75 mM KC1 
or veratridine 10 -4 M) in the presence or absence of the above 
antagonists or galanin. Two control flasks were prepared with 
no antagonist or agonist for each experiment. Lobules and media 
were separated, and lobules were mechanically homogenized in 
a 1% Triton X-100 buffer, pH 8.0, containing CaC12 2.5 mM, 
HEPES 25 raM, and KCI 0.1 M. The media and diluted ho- 
mogenate were analyzed for amylase  content. Mean percen*_~ge 
of total cellular amylase released during incubations for each rat 
was used for statistical analysis. 
Tritiated acetylcholine release. Acetylcboline (ACh) re!e~_~ from 
isolated lobules was determined using [ 3H ]ACh as  a marker .  
The same incubation buffer was used as in other lobule studies, 
with the addition of  physost~mine (50 ttM). Two lobules in 1 
ml buffer per flask were incubated with 0.2 I~M [3H]methyl cho- 
line chloride (specific activity, 88 Ci/mmoD for 1 hour at 370C 
under 95%O2/5%CO2. After initial radiolabelin~ lobules were 
washed twice with fresh buffer containing hemicholinium (10 
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#M). A 30-min period for equilibration was followed by incu- 
bation in buffer (30 rain, 37°C) with veratridine (10 -4 M) or 
KCI (75 raM). After removal of media, lobules were solubilized 
with 1 ml Solvable (Du Pont) for 2 h at 55°C. Glacial acetic 
acid (100 ~1) was then added to the solubilized tissue, and finally 
10 ml Ecolite was added for scintillation counting. Measured 
counts per minute was used for analysis. Released tritium was 
confirmed to be acetylcholine by separation on a 0.5 × 50 cm 
ion exchange column (Bio-Rex 70, 200-400 mesh, Bio-Rad) 
eluted with Na2HPO4 0.1 M at pH 7.0 (14). 
Stat&tical Methods 
Two-way analysis of variance was performed on all in vivo 
and acinar preparation results, and when significant differences 
(p < 0.05) were noted, individual Bonferroni t-tests were per- 
formed on analogous pairs to ascertain differences. Lobule prep- 
aration results were analyzed with paired Student's t-tests. All 
results are reported as mean _+ SEM. 
R E S U L T S  
In Vivo Effect of Galanin on Pancreatic Exocrine Function 
Intravenous infusion of galanin (40 #g/kg/h) did not affect 
basal amylase output from anesthetized rats (Fig. 1). Adminis- 
tration of 2-deoxy glucose (100 mg/kg subcutaneously) signifi- 
cantly stimulated amylase release. Increases were noted within 
10 min of injection, were maximum by 40 min, and remained 
elevated relative to baseline throughout the entire study period. 
2-Deoxy glucose-stimulated amylase secretion was significantly 
reduced by intravenous infusion of galanin, with inhibitory ef- 
fects noted throughout the 80-min experimental period, F(1, 
11) = 36.6, p < 0.001 (Fig. i). Maximal amylase secretion was 
5.8 --- 0.1 times baseline for control rats, and 3.1 ___ 0.1 times 
baseline for galanin-treated rats, a 47% reduction relative to 
control. Total integrated amylase secretion was calculated for 
the 80-min experimental period for both galanin infusion and 
control groups. Integrated amylase secretion was significantly 
decreased in the group of rats exposed to galanin, F(1, 1) = 7.14, 
p < 0.02 (Fig. 1). 
Pancreatic secretory response to intravenous CCK-8 (0.25 
#g/kg/h) was significantly increased throughout the experimental 
period (Fig. 2). Continuous intravenous infusion ofgalanin (40 
/=g/kg/min) produced significant suppression of CCK-8-stimu- 
lated exocrine secretion during the 80-rain experimental period, 
F(I ,  11) = 12.2,p < 0.001 (Fig. 2). Integrated amylase secretion 
following CCK stimulation was decreased by 41% in animals 
receiving galanin coinfusion, F(1, 1) = 3.45, p = 0.07. 
Bethanechol infusion (3 mg/kg/h) also stimulated pancreatic 
amylase secretion, with significant increases noted by 10 rain 
and plateau values by 30 rain. Continuous intravenous infusion 
of galanin (40/=g/kWh) during bethanechol infusion resulted in 
no significant suppression of integrated amylase output, F(1, 1) 
= 0.51, p = 0.48 (Fig. 3). 
In Vitro Effects of Galanin on Pancreatic Exocrine Function 
Dispersed acini. Galanin had no effect on basal amylase re- 
lease from dispersed acini. Basal amylase release was 4.5 + 0.6% 
of  total cellular content and incubation of acini in the presence 
of varying concentrations ofgalanin (10 -~3 to 10 -s M) produced 
no significant change (Table 1). 
Exposure of acini to incremental concentrations of betha- 
nechol (10 -7 to 10 -3 M) resulted in a dose-dependent increase 
in amylase release (Fig. 4). Maximal release was noted at 3 × 
10 -5 M bethanechol. Coincubation of bethanechol with galanin 
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FIG. 2. Effects ofgalanin on cholecystokinin octapeptide (CCK-8)-stim- 
ulated exocrine pancreatic function. Galanin (40 tzg/kg/h) was infused 
from 20-120 min, and CCK-8 (0.25 t~g/kg/h) was infused from 40-120 
rain. All values beyond 40 rain are significantly different from control. 
Decreases in integrated amylase secretion did not achieve statistical sig- 
nificance (p = 0.07); n = 6 for both groups. 
(10 -s or 10 -6 M) produced no change in amylase release relative 
to bethanechol alone, F(2,9) = 0.24, p = 0.99. Amylase release 
from acini incubated with cholecystokinin (10 -~3 to 10 -s M) 
increased in a dose-dependent fashion, with maximal release at 
10 -1° M. Coincubation with galanin (10 -s or 10 -6 M) had no 
significant effect on CCK-8 stimulated amylase release, F(2, 11) 
= 1.4, p = 0.12. 
Isolated lobules. Amylase release. Basal amylase release from 
isolated lobules averaged 2.8 __. 0.5% of tissue content. Lobules 
incubated with KCI (75 mM) released 4.6 ___ 0.4% of total amylase 
content (Fig. 5). Release in response to potassium was signifi- 
cantly inhibited by preincubation of lobules with galanin (10 -6 
M). Atropine (10 -5 M) completely abolished potassium-stimu- 
lated amylase release. 
Lobules incubated with veratridine (10 -4 M) released 5.9 + 
0.6% of total cellular amylase. Veratridine-stimulated amylase 
release was significantly inhibited by preincubation with galanin 
(10 -6 M). Preincubation with atropine (10 -5 M) significantly 
suppressed amylase release, while tetrodotoxin (10 -5 M) resulted 
in complete inhibition of veratridine-stimulated amylase release. 
Tritiated acetylcholine release. Basal [3H]ACh release from pan- 
creatic lobules was 5.5 --- 0.5% of total tissue content. When 
stimulated by KCI (75 mM), [3H]ACh release was increased to 
10.1 + 0.6% (Fig. 6). Galanin 10 -6 M significantly inhibited 
potassium-stimulated [3H]ACh release. Incubation of labeled 
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FIG. 3. Effects ofgalanin on bcthanechol-stimulated exocrine pancreatic 
function. Galanin (40/~g/kedh) was infused from 20-120 min, and be- 
thanochol (3 mg/kg/h) was infused from 40-120 rain. The lower panel 
illustrates integrated amylase secretion in the presence or absence of 
galanin, n = 6 for both groups. 
lobules with veratridine (10 -4 M) increased [3H]ACh release to 
12.4 _+ 1.7%. Stimulated release of ACh was significantly inhib- 
item by galanin 10 -6 M. Tetrodotoxin further inhibited veratri- 
dine-stimulated [3H]ACh release. 
DISCUSSION 
The results of the current study suggest that gaianin is an 
inhibitor of rat pancreatic exocrine secretion in vivo. When ad- 
ministered by continuous infusion, galanin caused sustained in- 
hibition of pancreatic exocrine secretion stimulated by 2-DG or 
CCK-8. Yagci and coworkers have also recently reported that 
galanin inhibits CCK-8-stimulated pancreatic secretin in the 
anesthetized rat (31). In the presem investigation, bethanechol- 
stimulated amylase secretion was not affected by galanin. In- 
hibitory actions do not appear to be exerted directly upon the 
acinar cell, as galanin had no inhibitory activity in vitro upon 
dispersed acini. Galanin did not affect basal amylase release from 
dispersed acini, and amylase release in dispersed acini stimulated 
by bethaneehol or CCK-8 incubation was not altered by coin- 
eubation with galanin. For dispersed acini, the current results 
differ significantly from those of Ahren and cow-'orkers (1). These 
investigators have previously relx)rted that galanin inhibits am- 
ylase release when isolated rat acini were exposed to CCK-8 in 
concentrations similar to those used in the current study. 
The current studies utilizing pancreatic lobules suggest that 
inhibition of pancreatic exocrine function by galanin may be 
TABLE 1 
DISPERSED ACINI INCUBATED WITH GALANIN OVER 
A RANGE OF CONCENTRATIONS 
Galanin Concentration Amylase Released* SEM 
Zero (control) 
× lO -13 M 
3 × 10 -13 M 
× 10 -12 M 
3 × 10 -12 M 
× 10-lJ M 
3 × 10-11 M 
× 10 -Io M 
















* Expressed as mean percentage of total cellular amylase 
released into the media. 
mediated, at least in part, by modulation ofintrapancreatic cho- 
linergic neurotransmission. C-alanin significantly decreased the 
release of amylase when pancreatic lobules, which contain in- 
trapancreatic nerve terminals as well as islets, were exposed to 
the depolarizing agents veratridine or KCI. In separate exped- 
24 o Control 
# 16 
2. -/'3 -1'2 41 -t'o -~ -b 
CCK-8 (log M) 
20 o Control . 
. .  .~, .~ .g . i  .a 
Bethanechol (log M) 
FIG. 4. Amylase release from dispersed ~ incubated with ~ o 1  
or cholecystokinin oclapaptid¢ (CCK-8) in the ~ n c e  or presence of 
galanin 10 -s M. Bethanechol concentrations ~ ~ms!O-' to 10:3 
M and CCK-8 concentrations ~ from 10- s to to lO ~ M. Galanin 
at 10 -~ M produced similar result~ All amays wue performed ia dulleme. 
n = 6 for each group, Error bars are omitted for clarity; atlSEMs < 10%. 
GALANIN INHIBITS EXOCRINE PANCREAS 491 
ments, decreased release of [3H]ACh from pancreatic lobules in 
response to stimulation by these agonists was also noted with 
galanin coincubation. 
The ability of galanin to affect pancreatic function indirectly 
via actions on intrapancreatic neurons has also been suggested 
for other, structurally unrelated, pancreatic neuropeptides. Pan- 
creatic polypeptide has been reported to inhibit bethanechol-, 
CCK-8-, and 2-DG-stimulated exocrine pancreatic function in 
vivo. (5,23). Inhibition is believed to involve presynaptic mod- 
ulation of acetylcholine release (14). Neuropeptide Y, which 
shares sequence homology with pancreatic polypeptide, has also 
been shown to have indirect inhibitory effects on exocrine pan- 
creatic function consistent with effects on cholinergic transmis- 
sion (18). Somatostatin has also been shown to act indirectly to 
modulate exocrine secretion (25). From experiments using iso- 
lated perfused rat pancreas, Mulvihill et al. concluded that so- 
matostatin inhibition was mediated via effects on intrapancreatic 
peptidergic neurons (20). 
In enteric neurons, galanin does not affect basal acetylcho- 
line release, but the peptide does inhibit acetylcholine release 
stimulated by electrical current, vasoactive intestinal peptide, 
or substance P (32). Galanin causes neuronal membrane hy- 
perpolarization by opening potassium channels, thereby de- 
creasing input resistance and suppressing excitability. Galanin 
has also been noted to block voltage-gated calcium channels 
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FIG. 6. Tritiated acetylcholine release from isolated lobules (n = 6 per 
group) incubated with KCI (75 mM) or veratridine (10 -4 M) with or 
without galanin (10 -6 M) or tetrodotoxin (TTX, 10 -5 M). 
been noted to inhibit acetylcholine release from hippocampal 
slices (22). 
Inhibitory effects of  galanin have also been noted in pan- 
creatic endocrine tissues. Galanin suppresses insulin release by 
inhibiting adenylate cyclase in the insulin-secreting cell line 
RINm5F (3). Galanin inhibition of  insulin release appears to 
act via blockade of exocytosis secondary to effects on beta cell 
membrane G-proteins; inhibitory effects are blocked by per- 
tussis toxin (21,28). 
While the current data indicate that galanin affects exocrine 
function, at least in part, via inhibition of cholinergic neurons, 
other mechanisms of action for galanin are not excluded. The 
in vivo effects of galanin could be secondary to pancreatic va- 
soconstriction. Pancreatic galanin has been shown to be released 
by bilateral thoracic splanchnic nerve stimulation, and the pep- 
tide has been shown to coexist with epinephrine and norepi- 
nephrine in intrapancreatic and celiac neurons (2,18). Since 
galanin inhibits the release of somatostatin (10,17), and since 
somatostatin itself decreases with mixed pancreatic nerve stim- 
ulation, the involvement of this peptide seems unlikely (4). 
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